Artiva Biotherapeutics, Inc.

ARTV·NASDAQ·$7.67Share Price as of 11/2·$190MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/08/26 10-K/AFY 202504/30/26 10-KFY 202503/10/26 10-QQ3 ended 09/30/2511/12/25

Disclosures

8-KCurrent report10/27/26 8-KCurrent report09/11/26 8-KCurrent report08/06/26 8-KCurrent report07/22/26 8-KCurrent report05/19/26

Prospectuses and Registrations

S-8Registration of securities for employees09/11/26 S-3Shelf registration08/06/26 424B5Prospectus supplement05/08/26 FWPFree writing prospectus05/08/26 S-8Registration of securities for employees03/10/26

Proxies

DEF 14ADefinitive proxy08/03/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25

Ownership

Form 4Insider transaction10/07/26 144Proposed sale of securities10/06/26 Form 4Insider transaction10/06/26 Form 4Insider transaction10/06/26 Form 4Insider transaction10/06/26

Other

EFFECTRequest for effectiveness08/14/26 ARSAnnual report to shareholders08/03/26 EFFECTRequest for effectiveness08/15/25 CORRESPCorrespondence with the SEC08/13/25 UPLOADLetter from the SEC08/11/25